Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19

NCT04871776 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04871776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 18, 2022
Completion date
August 17, 2022
Enrollment
3,671 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, vaccine refusal